Edesa Biotech, Inc. (EDSA)

Edesa Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	15	14	13	14	98	78
Market Cap Growth	28.33%	8.40%	-6.42%	-85.44%	26.16%	65.89%
Enterprise Value	1	12	7	1	90	75
Last Close Price	2.14	4.45	4.42	6.45	51.66	56.49
Forward PE	-	-	-	56.67	-	-
PS Ratio	-	-	-	-	-	235.84
PB Ratio	2.37	7.29	1.89	1.52	7.49	8.51
P/TBV Ratio	3.48	-	2.74	2.00	9.16	18.70
EV/Sales Ratio	-	-	-	-	-	226.70
Debt / Equity Ratio	-	0.01	0.01	0.00	0.01	0.02
Asset Turnover	-	-	-	-	-	0.04
Quick Ratio	15.61	0.71	3.29	3.90	7.64	4.77
Current Ratio	15.73	0.91	3.53	4.25	8.29	5.30
Return on Equity (ROE)	-58.78%	-136.66%	-101.88%	-156.34%	-120.39%	-88.61%
Return on Assets (ROA)	-35.30%	-69.02%	-56.33%	-87.78%	-116.79%	-48.55%
Return on Capital (ROIC)	-40.62%	-95.89%	-69.64%	-101.75%	-131.97%	-55.07%
Earnings Yield	-38.81%	-42.70%	-62.82%	-123.19%	-13.64%	-8.21%
FCF Yield	-38.05%	-33.84%	-49.78%	-86.24%	-13.98%	-6.44%
Buyback Yield / Dilution	-22.97%	-11.84%	-36.37%	-21.50%	-40.32%	-87.63%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q